Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »
Reset 

Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Ultimovacs ASA

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  TScan Therapeutics, Inc.

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  PaxMedica, Inc.

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Globus Medical Inc.

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Hookipa Pharma Inc.

CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  CVRx, Inc.

INVO Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  INVO Bioscience, Inc.

Panbela Announces Transfer to OTCQB Market

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Panbela Therapeutics, Inc.

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Alvotech

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Alvotech

Renowned Alzheimer's Neurologist Dale Bredesen, MD, Joins Pacific Neuroscience Institute

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Solis Mammography and Northwest Healthcare Announce Strategic Joint Venture to Enhance Women's Health in the Tucson Market

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

FDA Roundup: April 16, 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  U.S. Food and Drug Administration

NeuroX, American TelePhysicians' Brain Health Division, Selected as Participant in CMS GUIDE Program

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  TransMedics, Inc

New Findings in JNCCN Illustrate Pathway for Screening High-Risk Individuals for Pancreatic Cancer in PRECEDE Study

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  EmVenio Research

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Viatris Inc.

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Amgen Inc.

Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »
to the top ↑